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Introduction: Patients undergoing operations to treat peripheral vascular disease have systemic atherosclerosis and are at
risk for stroke. However, the incidence and effect of cerebrovascular events on noncarotid vascular surgical outcomes are
not well-defined.
Methods: Patients undergoing common operations for vascular disease from 1997 to 2000 were examined with data from
the Veterans Affairs (VA) National Surgery Quality Improvement Project and the VA patient treatment files. Operations
studied included abdominal aortic aneurysmectomy (n  2551), aortobifemoral bypass (n  2616), lower extremity
bypass (n  6866), and major lower extremity amputation (n  7442). The incidence of perioperative stroke was
determined, and logistic regression analysis was used to identify independent risk factors for stroke. Logistic and linear
regression analyses were used to quantify the effect of postoperative stroke on adjusted mortality and length of stay. Odds
ratio (OR) and 95% confidence interval (CI) were defined. P < .05 was considered significant.
Results: Stroke was uncommon after noncarotid vascular procedures, occurring in only 0.4% to 0.6% of patients.
Independent risk factors for stroke include preoperative ventilation (OR, 11; 95% CI, 5.0-22.3; P < .001), previous
stroke or transient ischemic attack (OR, 4.2; 95% CI, 2.7-6.4; P < .001), postoperative myocardial infarction (OR, 3.3;
95% CI, 1.3-8.7; P .009), and need to return to the operating room (OR, 2.2; 95% CI, 1.4-3.5; P .001). Factors that
did not appear to be associated with stroke risk included procedure type, diabetes, renal failure, dialysis dependence,
number of transfused units of blood, and hypertension. After controlling for other postoperative complications and
comorbid conditions, postoperative stroke significantly increased the risk for perioperative mortality (OR, 6.3; 95% CI,
3.4-11.4; P < .001), with similar magnitude as postoperative myocardial infarction (OR, 6.3; 95% CI, 3.9-10.1; P <
.001). Stroke was also associated with a 48% increase in overall length of stay.
Conclusions: Stroke after noncarotid peripheral vascular surgery is uncommon, but results in markedly increased mortality
and length of stay. Stroke risk is most strongly associated with previous stroke history and greater degree of illness.
Patients with these associated conditions deserve particular attention to assessing and medically managing modifiable risk
factors. (J Vasc Surg 2004;39:67-72.)
Stroke after noncarotid vascular surgical procedures is a
feared complication. It is well-recognized that most strokes
are related to systemic atherosclerosis and that most are
embolic, originating from an extracranial vascular origin.1
Carotid endarterectomy (CEA) is a well-proved therapy to
prevent stroke in patients with significant carotid artery
stenosis, but many patients undergoing vascular surgical
procedures do not have a defined lesion. Many of the same
risk factors for stroke are those that lead patients to surgical
interventions to treat aneurysmal or occlusive vascular dis-
ease.
Stroke as a complication of aortic aneurysm surgery in a
large, multicenter trial varied from 0.2% in patients without
a history of stroke to 3.1% in those with a history of stroke.2
Similarly, in large single-institution studies the reported
risk varied from 1.7% to 2.3%.3,4 The incidence of stroke in
patients undergoing lower extremity bypass procedures has
been estimated at 0.5% to 2%.3,5 Unlike risk assessments for
perioperative myocardial infarction with well-delineated
history and electrocardiographic findings,6 no similar fac-
tors have been identified to place a particular patient at risk
for perioperative stroke.
The current study was conducted to determine the
multicenter incidence of stroke in patients undergoing
major noncarotid vascular surgery. The relationship be-
tween stroke and the patient’s preoperative comorbid con-
ditions, intraoperative course, and postoperative complica-
tions was examined to determine factors associated with a
higher risk for stroke. Finally, the effect on mortality and
resource use associated with perioperative stroke was as-
sessed.
METHODS
Data sources. All male patients who underwent major
vascular surgical procedures (N  20,037) from 1997
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through 2000 were identified from the Department of
Veterans Affairs (VA) Patient Treatment File (PTF) data-
base. Data were abstracted for patients undergoing three
specific types of procedures by using International classifi-
cation of diseases, ninth revision, Clinical modification
(ICD-9-CM) codes: abdominal aortic procedures (38.36,
38.44, 38.45, 39.24-39.26), lower extremity revasculariza-
tion (38.48, 38.68, 39.29), and lower extremity major
amputation (84.15, 84.17). PTF data included demo-
graphic information, condition of patient at discharge, and
hospital length of stay (LOS).
Patient records were then linked to the National Surgi-
cal Quality Improvement Program (NSQIP) database of
surgical procedures performed at VA hospitals. The NSQIP
is a prospective, multicenter observational evaluation
project to assess risk-adjusted surgical outcomes within the
VA hospital system.7,8 This database includes demographic
information; preoperative comorbid conditions, including
history of bleeding disorders, tobacco use, low albumin
concentration (3.5 mg/dL), significant weight loss, and
alcohol abuse7; intraoperative care; and postoperative out-
comes, collected by trained nurse reviewers at each of the
123 VA medical centers. All operations performed with the
patient under general, spinal, or epidural anesthesia were
included, unless the patient had undergone another index
procedure within the previous 30 days.
Data linkage was accomplished with use of scrambled
patient identifiers, date of admission, and procedure type.
Patient confidentiality was ensured by removing all patient-
identifiable information, including scrambled identifiers.
This project was approved by the Institutional Review
Committee of the Ann Arbor VA Health Care System.
Definition of surgical procedures. Patients were
classified into one of three mutually exclusive classifications
on the basis of the specific procedure, with the following
hierarchy: aortic reconstruction, lower extremity bypass,
and amputation. Accordingly, a patient who underwent
both aortic repair and lower extremity bypass was consid-
ered in the aortic repair category. Patients whose primary
procedure was classified as emergent within the NSQIP
database were excluded from the study.
Definition of independent variables. Demographic
information collected from the PTF file included patient
age, race, and gender. Additional independent variables
were defined with NSQIP definitions, and included history
of congestive heart failure within 1 month of surgery;
history of chronic obstructive pulmonary disease resulting
in one or more factors such as functional disability, chronic
bronchodilator therapy, or forced expiratory volume in 1
second less than 75% of predicted; history of a transient
ischemic attack (TIA); history of stroke (embolic, throm-
botic, hemorrhagic), with residual motor, sensory, or cog-
nitive deficit; ethanol abuse (more than two drinks per day)
in the 2 weeks before admission; current smoker; ventila-
tor-dependent preoperatively; receiving steroid therapy
preoperatively; and receiving dialysis preoperatively. Data
were also assessed regarding intraoperative blood loss, and
postoperative events including myocardial infarction and
need for cardiopulmonary resuscitation were determined
from the NSQIP database. Because the NSQIP does not
collect prospective data on hypertension, discharge diagno-
sis codes were used to identify patients with hypertension.
Definition of surgical outcomes. The three primary
outcomes were stroke within 30 days of the principal pro-
cedure; death within 30 days of operation; and length of
stay (LOS), including total residence in the acute care
hospital.
Statistical analysis. Differences in baseline character-
istics and clinical outcomes among patients who had a
stroke and those who did not were evaluated with the 2
test for categorical variables and the two-tailed Student t
test for continuous variables. Multivariable logistic regres-
sion models were then developed for the primary outcomes
of stroke and death, entering the univariate variables with P
 .1. For analysis, patients undergoing abdominal aortic
aneurysm (AAA) repair, aortofemoral bypass procedures,
and aortovisceral bypass procedures were subsequently
combined into a single category of aortic surgery. Similarly,
patients undergoing lower extremity bypass procedures to
treat occlusive and aneurysmal disease were grouped in the
category of lower extremity reconstructions. Finally, pa-
tients undergoing above-knee or below-knee amputations
were considered together. Procedure type was used as a
categorical variable, with amputation picked a priori as the
comparison group. A subsequent model using linear re-
gression was developed to assess the effect of postoperative
stroke on LOS.
Model performance was assessed with formal good-
ness-of-fit (Hosmer-Lemonshow) tests, comparing the ex-
pected and observed events in 10 equal subgroups defined
by the deciles of predicted risk. A statistically nonsignificant
goodness-of-fit statistic is evidence of model discriminant
capacity. All models showed evidence of adequate calibra-
tion at both visual and statistical inspection. Data were
analyzed with Stata version 6.0 (Stata Corp, College Sta-
tion, Tex).
RESULTS
Patients in this study undergoing major vascular sur-
gery at VA medical centers, including 5296 abdominal
aortic procedures (AAA, 2551; aortofemoral bypass, 2616;
other, 129), 7299 lower extremity vascular reconstruc-
tions, and 7442 major limb amputations, had typical sig-
nificant risk factors for cerebrovascular disease (Table I).
Postoperatively, 1.1% to 2.2% of patients experienced car-
diac arrest and 1.1% to 2.0% sustained a myocardial infarc-
tion.
The overall incidence of stroke within 30 days of oper-
ation varied from 0.4% in patients undergoing lower ex-
tremity procedures to 0.6% in patients undergoing an am-
putation (Table II). Overall, 9.8% of strokes occurred
within 1 day of operation, and 50% occurred within 1 week.
The 30-day mortality rate was similarly low, ranging from
1.3% in the lower extremity revascularization group to 3.8%
in patients undergoing major amputations. Mean LOS was
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13 days for aortic procedures, 16 days for lower extremity
procedures, and 30 days for amputations.
Univariate analysis revealed significant associations be-
tween postoperative stroke and patient comorbid condi-
tions and postoperative course (Table III). Comorbid med-
ical conditions most closely correlated with stroke were
need for mechanical ventilation before the operation (odds
ratio [OR], 13.9; 95% confidence interval [CI], 6.9-28.0),
history of stroke (OR, 4.6; 95% CI, 3.1-6.8), history of
congestive heart failure (OR, 2.2; 95% CI, 1.2-3.8), and
perioperative coagulopathy (OR, 2.2; 95% CI, 1.0-4.7).
Postoperative complications associated with increased
stroke included myocardial infarction (OR, 4.6; 95% CI,
2.0-10.5), postoperative cardiac arrest (OR, 3.5; 95% CI,
1.5-8.2), and need to return to the operating room (OR,
2.1; 95% CI, 1.4-3.3). Factors that did not appear to be
associated with stroke risk included procedure type, anes-
thetic type, diabetes, renal failure, dialysis dependence,
number of transfused units of blood, smoking, alcohol
abuse, extensive weight loss, and hypertension (P .10 for
all).
Multivariate logistic regression analysis confirmed an
independent association between stroke and need for pre-
operative ventilation, previous stroke, postoperative myo-
cardial infarction, increased age, and need to return to the
operating room (Table III). Aortic procedures were asso-
ciated with a higher risk for stroke, compared with ampu-
tations (OR, 1.7; 95% CI, 1.0-2.8). Coagulopathy, previ-
ous congestive heart failure, and postoperative cardiac
arrest were not independently associated with stroke (P 
.10).
Postoperative stroke had a significant effect on mortal-
ity and LOS. Patients undergoing aortic procedures who
had a stroke had a mortality rate of 10.3%, compared with
only 2.7% in patients without stroke (P  .01). Similarly,
stroke increased mortality after lower extremity reconstruc-
tion, from 1.2% to 15.6% (P  .001), and amputations,
from 3.7% to 19.5% (P   .001). Overall, stroke signifi-
cantly increased the risk for death (OR, 7.2; 95% CI,
4.2-12.3; Table IV). This risk was exceeded only by the risk
associated with postoperative cardiac arrest (OR, 94.0; 95%
CI, 73-119) and postoperative myocardial infarction (OR,
15; 95% CI, 11.8-20.8). The independent effect on mor-
tality of postoperative stroke (OR, 6.3; 95% CI, 3.4-11.4)
was equivalent to postoperative myocardial infarction (OR,
6.3; 95% CI, 3.9-10.1), and approached the risk associated
with postoperative renal failure (OR, 7.9; 95% CI, 4.1-
15.2).
Mean LOS was significantly increased, from 13 to 27
days (P  .001), in aortic procedures complicated by
stroke, and from 16 to 39 days (P .001) when associated
with lower extremity procedures. Patients undergoing am-
putation had an insignificant increase in mean LOS, from
30 to 34 days (PNS). Multivariate analysis demonstrated
that stroke was associated with a mean increase in LOS of
4.7 days (data not shown).
DISCUSSION
Postoperative stroke in patients undergoing noncarotid
vascular surgical procedures is uncommon, with an inci-
dence of less than 1%, but with an associated sixfold in-
Table II. Principle outcomes
Aortic
procedures
Lower extremity
procedures Amputations
Postoperative stroke (%) 0.5 0.4 0.6
Death within 30 days
(%)
2.7 1.3 3.8
Length of stay (d) 13 16 30
Table III. Factors associated with stroke
Univariate
analysis
Multivariate
analysis
OR 95% CI OR 95% CI
Aortic procedure 1.1 0.7–1.7 1.7 1.0–2.8
Lower extremity bypass 0.7 0.5–1.2 1.1 0.7–1.8
Age (per year) 1.03 1.0–1.1 1.02 1.0–1.04
Bleeding disorder 2.2 1.0–4.7
Need for return to OR 2.1 1.4–3.3 2.2 1.4–3.5
Cardiac arrest 3.5 1.5–8.2
Postoperative MI 4.6 2.0–10.5 3.3 1.3–8.7
Previous CVA 4.6 3.1–6.8 4.2 2.7–6.4
History of CHF 2.2 1.2–3.8
Preoperative ventilation
therapy
13.9 6.9–28.0 10.6 5.0–22.3
ROC 0.75
OR, Odds ratio; CI, confidence interval; OR, operating room; MI, myocar-
dial infarction; CVA, cerebrovascular accident; CHF, congestive heart fail-
ure; ROC, receiver operating characteristic.
Table I. Patient demographic data
Aortic
operations
(n  5296)
Lower
extremity
operations
(n  7299)
Amputations
(n  7442)
Mean age (y) 66 66 68
Race (%)
White 83 75 65
Black 8 16 26
Previous CVA (%) 13 17 26
History of bleeding
disorders (%)
1.8 3.1 4.6
Cardiac arrest (%) 1.9 1.1 2.2
Myocardial infarction
(%)
2.0 1.1 1.4
Dialysis (%) 0.6 3.2 9.1
Diabetes (%) 14 41 59.6
History of CHF (%) 2.7 4.9 11.6
Units of RBCs
transfused
1.7 0.3 0.2
Need for return to
OR (%)
9.2 21.8 16.5
Ventilator-dependent
before OR (%)
0.8 0.3 1.2
CVA, Cerebrovascular accident; CHF, congestive heart failure; RBCs, red
blood cells; OR, operating room.
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crease in the odds for death, and a significantly longer LOS.
Occurrence of stroke compares with a 1% to 2% risk for
perioperative myocardial infarction in the same group of
patients. Noncarotid vascular surgery–related stroke has
not previously been well-defined outside of postcoronary
artery bypass series, or only as a subanalysis in other large
vascular surgery series. The utility of a prospectively ac-
quired database, such as the NSQIP, is attractive for ana-
lyzing rare postoperative complications such as stroke, and
is a potentially valid means of measuring quality of care in
non-federal hospitals.8,9 The detailed chart data regarding
specific causes, such as proximate atrial fibrillation, carotid
artery occlusive disease, and perioperative anticoagulation,
were not available, and is a limitation of this study.
Previous stroke was one of the strongest independent
risk factors for postoperative stroke. Thus we believe that
factors such as perioperative hypotension should be
avoided, because previously damaged vasculature may be at
increased risk for vasospasm or leakage.1 As a result of the
intrinsic limitations of the study data, hemorrhagic causes
could not be delineated from embolic causes, because
computed tomography scans were not available. Moreover,
whether previous stroke was due to an anatomic cause that
had since been repaired (eg, CEA) or to an intracerebral
vascular cause was unknown, and how this might relate to
later stroke risk is speculative. Whether some type of func-
tional brain imaging, such as positron emission tomogra-
phy, should be done in patients with a history of stroke
before an elective vascular operation is intriguing.
Many strokes occurred several days postoperatively and
after a period of lucency, leading to questions regarding the
importance of intraoperative factors.4,10 Indeed, most
strokes occurred after the first 48 hours but within a week
postoperatively, similar to when postoperative myocardial
infarctions occur. Consistent with this observation was that
no relationship between postoperative stroke and the num-
ber of intraoperative transfusions required (as an indirect
measurement of degree of intraoperative blood pressure
lability) was found. Preoperative ventilation therapy con-
veys a very high risk for stroke, and probably represents a
surrogate marker for critically ill patients, rather than as a
direct cause of stroke. Finally, in multivariate analysis, pa-
tients undergoing aortic procedures appear to be at higher
risk for stroke than patients undergoing either lower ex-
tremity procedures or amputation. This finding is further
suggestive that physiologic stress of the operation itself has
an important role in postoperative stroke, as it does in
myocardial infarction.
These results are concordant with another large study
of stroke incidence after noncarotid vascular surgery.4 In a
report of 1390 patients undergoing noncarotid vascular
operations, including aortic reconstruction and lower ex-
tremity bypass, the overall incidence of stroke or TIA was
0.9%. In a matched-pair analysis of these cases, aortic
procedures in patients with greater than 50% ipsilateral
internal carotid artery stenosis were at greater risk for
stroke. Similarly, there is a significant increase in the risk for
stroke after AAA repair in patients with a history of stroke.2
The close relationship between history of stroke and a
second perioperative stroke in the current study is in agree-
ment with previous investigations. In one such study the
incidence of stroke among 173 patients with previous
stroke receiving general anesthesia for general and vascular
operations was 2.9%, far higher than that reported for
patients without a history of stroke.11
Table IV. Factors associated with death within 30 days
Bivariate analysis Multivariate analysis
OR 95% CI OR 95% CI
Stroke 7.2 l4.2–12.3 6.3 3.4–11.4
Aortic operation 0.3 0.2–0.4 0.6 0.5–0.9
Lower extremity operation 0.9 0.6–1.3 0.5 0.3–0.6
Age 1.04 1.04–1.06 1.04 1.02–1.05
Bleeding disorder 2.0 1.4–2.9
Cardiac arrest 94.0 73–119 59.5 43.4–81.3
Postoperative MI 15 11.8–20.8 6.3 3.9–10.1
Previous CVA 1.6 1.3–1.9
Dialysis dependence 3.4 2.6–4.4 2.3 1.5–3.5
Insulin-dependent diabetes 1.3 1.1–1.6
History of CHF 3.2 2.6–4.1 1.6 1.1–2.3
History of COPD 1.7 1.4–2.1
Smoking 0.6 0.5–0.7
Postoperative renal failure 4.5 3.0–6.7 7.9 4.1–15.2
Need for postoperative transfusion 2.2 1.3–3.6
Preoperative ventilation therapy 5.8 3.5–9.4
Low albumin concentration 2.9 2.1–4.1 1.5 0.9–2.5
Significant weight loss 2.8 2.1–3.7 1.5 0.9–2.3
Preoperative sepsis 5.3 4.1–6.9 2.7 1.7–4.3
ROC 0.89
OR, Odds ratio; CI, confidence interval; MI, myocardial infarction; CVA, cerebrovascular accident; CHF, congestive heart failure; COPD, chronic obstructive
pulmonary disease; ROC, receiver operating characteristic.
JOURNAL OF VASCULAR SURGERY
January 200470 Axelrod et al
No imaging data regarding the extracranial vascular
anatomy were available for analysis in the current study,
which leads to the possibility that some of these patients
may have had a potentially surgically correctable lesion that,
if treated with CEA preoperatively, may have reduced the
risk for stroke. However, most patients undergoing vascu-
lar surgery are assessed with history and physical examina-
tion that includes screening for carotid artery occlusive
disease.12 The value of routine preoperative carotid duplex
ultrasound scanning in all vascular surgery patients to iden-
tify silent carotid occlusive disease remains controversial.
The estimated incidence of significant carotid artery steno-
sis (70%) has been reported to be 2.1% to 9% among
patients undergoing AAA repair.13,14 Among patients with
significant peripheral vascular occlusive disease, as many as
60% will have evidence of some degree of carotid artery
stenosis.15 While the incidence of coexistent carotid artery
occlusive disease is high (like coronary heart disease), most
clinically important lesions will be associated with either a
history of stroke, TIA, or previous CEA. In one study of
AAA repairs the absence of a positive clinical history and
physical examination had a 99% negative predictive value
for the presence of advanced (80%) carotid artery steno-
sis, rendering routine screening not cost-effective.12 Fur-
thermore, there is no evidence that routine, preoperative
CEA is of benefit in patients who do not meet criteria for
repair of symptomatic carotid occlusive disease.4
Despite the low risk for perioperative stroke in patients
undergoing vascular surgery, they remain at elevated stroke
risk compared with the general population, on the basis of
increased prevalence of comorbid conditions such as hyper-
tension, diabetes, and tobacco use. Therefore vascular sur-
gical procedures should be viewed as an opportunity to
intervene to reduce the long-term risk for stroke. It has
become increasingly clear, on the basis of level I medical
evidence, that patients with manifestations of systemic ath-
erosclerosis, such as claudication, coronary heart disease,
and stroke, should be receiving cardioprotective medica-
tions. These include anti-platelet therapy, 3-hydroxy-3-
methylglutaryl coenzyme A reductase agents (statin drugs),
and angiotensin converting enzyme inhibitors.16-19 In-
deed, these recommendations are part of an American
Heart Association consensus statement.20 The thienopyri-
dine derivative clopidogrel may have a slight advantage
over aspirin in preventing stroke, although this has not
been assessed in the postoperative setting.21 Moreover,
perioperative aspirin therapy in patients undergoing coro-
nary bypass was associated with a 50% reduction in stroke.22
Statin agents have a significant protective effect against
nonhemorrhagic stroke in medical patients.23,24 On the
basis of studies that suggest an advantage to use of peri–
cardiac procedure statin use,25,26 it is reasonable to recom-
mend that patients with a history of stroke be given statin
therapy before elective vascular procedures. -Blockade has
shown particular efficacy in patients undergoing vascular
procedures in reducing morbidity and mortality related to
myocardial events.27 Inasmuch as postoperative myocardial
infarction independently increased postoperative stroke
risk threefold, reduction of myocardial infarction will likely
reduce postoperative stroke incidence as well.
This study supports the recommendation that all pa-
tients undergoing noncarotid peripheral vascular surgery
should be carefully questioned about signs or symptoms
consistent with history of stroke. Those without anatomic
lesions but previous stroke should be counseled regarding
the increased perioperative risk for recurrent stroke, and
their risk factors should be medically minimized.
REFERENCES
1. Easton JD, Hauser SL, Martin JB. Cerebrovascular diseases. In: Fauci A,
Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al,
editors. Harrison’s principles of internal medicine. 14th edition. 1998.
2. Johnston KW, Scobie TK. Multicenter prospective study of nonrup-
tured abdominal aortic aneurysms. I: Population and operative manage-
ment. J Vasc Surg 1988;7:69-81.
3. Cruz CP, Drouilhet JC, Southern FN, Eidt JF, Barnes RW, Moursi
MM. Abdominal aortic aneurysm repair. J Vasc Surg 2001;35:335-44.
4. Harris EJ, Moneta GL, Yeager RA, Taylor LM Jr, Porter JM. Neuro-
logic deficits following noncarotid vascular surgery. Am J Surg 1992;
163:537-40.
5. Frangos SG, Karimi S, Kerstein MD, Harpavat M, Sumpio B, et al.
Gender does not impact infrainguinal vein bypass graft outcome. Sur-
gery 2000;127:679-86.
6. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, et al.
ACC/AHA guideline update for perioperative cardiovascular evalua-
tion for noncardiac surgery: executive summary. Anesth Analg 2002;
94:1052-64.
7. Khuri SF, Daley J, Henderson W, Hur K, Demakis J, Aust JB, et al. The
Department of Veteran Affairs NSQIP: the first national, validated,
outcome-based, risk adjusted, and peer controlled program for the
measurement and enhancement of the quality of surgical care. Ann Surg
1998;228:491-507.
8. Khuri SF, Daley J, Henderson W, Hur K, Hossain M. Relation of
surgical volume to outcome in eight common operations: results from
the VA National Surgical Quality Improvement Program. Ann Surg
1999;230:414-29.
9. Fink AS, Campbell DA Jr, Mentzer RM Jr, Henderson WG, Daley J,
Bannister J, et al. The National Surgical Quality Improvement Program
in non–Veterans Administration hospitals: initial demonstration of fea-
sibility. Ann Surg 2002;236:344-53.
10. Hagino RT, Rossi PJ, Rossi MB, Valentine RJ, Clagett GP. Asymptom-
atic carotid stenosis and unrelated operations: should we be more
aggressive? J Am Coll Surg 2001;192:608-13.
11. Landercasper J, Merz BJ, Cogbill TH, et al. Perioperative stroke risk in
173 consecutive patients with a past history of stroke. Arch Surg
1990;125:986-9.
12. Axelrod DA, Diwan A, Stanley JC, Jacobs LA, Henke PK, Greenfield
LJ, et al. Cost of routine screening for carotid and lower extremity
occlusive disease in patients with abdominal aortic aneurysms. J Vasc
Surg 2002;35:754-8.
13. Cheng SW, Wu LL, Lau H, Ting AC, Wong J. Prevalence of significant
carotid stenosis in Chinese patients with peripheral and coronary artery
disease. Aust N Z J Surg 1999;69:44-7.
14. Deville C, Kerdi S, Madonna F, de la Renaudiere DF, Labrousse L.
Infrarenal abdominal aortic aneurysm repair: detection and treatment of
associated carotid and coronary lesions. Ann Vasc Surg 1997;11:467-
72.
15. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a
reflection of a systemic process: implications for concomitant coronary
and carotid disease. Semin Vasc Surg 1999;12:118-22.
16. Patrono C. Aspirin as an anti-platelet drug. N Engl J Med 1994;330:
1287-94.
17. Heart Protection Study Collaborative Group. MRC/BHF heart pro-
tection study by cholesterol lowering with simvastatin in 20536 high
risk individuals: a randomized placebo-controlled trial. Lancet 2002;
360:7-22.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 1 Axelrod et al 71
18. Heart Outcomes Prevention Evaluation Study Investigators. Effects
of an angiotensin converting enzyme inhibitor, ramapril, on cardio-
vascular events in high risk patients. N Engl J Med 2000;342:145-
53.
19. Expert panel on detection, evaluation and treatment of high blood
cholesterol in adults: executive summary of the third report of the
National Cholesterol Education Program (NCEP). JAMA 2001;285:
2486-97.
20. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD. AHA/
ACC guidelines for preventing heart attack and death in patients with
atherosclerotic cardiovascular disease: 2001 update. Circulation 2001;
104:1577-9.
21. CAPRIE Steering Committee. A randomized blinded trial of clopi-
dogrel versus aspirin in patients at risk of ischemic events. Lancet
1996;348:1329-39.
22. Mangano DT. Aspirin and mortality from coronary bypass surgery.
N Engl J Med 2002;347:1309-17.
23. Byington RP, Davis BR, Plehn JF, White HD, Baker J, et al. Reduction
of stroke events with pravastatin: the prospective pravastatin pooling
project. Circulation 2001;103:387-92.
24. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, et al.
Pravastatin therapy and the risk of stroke. N Engl J Med 2000;343:317-26.
25. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, et al. With-
drawal of statins increases event rates is patients with acute coronary
syndromes. Circulation 2002;105:1446-52.
26. Herrmann J, Lerrman A, Baumgart D, Volbracht L, Schulz R, et al.
Preprocedural statin medication reduces the extent of perioproce-
dural non–Q wave myocardial infarction. Circulation 2002;106:
2180-3.
27. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven FLM, et al.
The effect of bisoprolol on perioperative mortality and myocardial
infarction in high risk patients undergoing vascular surgery. N Engl
J Med 1999;341:1789-94.
Submitted Jun 3, 2003; accepted Aug 7, 2003.
DISCUSSION
Dr Timothy F. Kresowik (Iowa City, Ia). Since lower ex-
tremity bypass procedures as well as amputations can be done
under either regional or general anesthesia, was type of anesthetic
a risk factor for stroke that you analyzed in the multivariate
analysis?
Dr David A. Axelrod. We did not analyze that; however we
do have that data, Dr Kresowik, and I think it will be certainly
worth analyzing it. Given the size of this dataset, I think we could
actually do a responsible subset analysis.
Dr Robert B. McLafferty (Springfield, Ill). After a stroke
occurs, there is usually an intense diagnostic workup to find out the
cause. You didn’t give us any data about whether these strokes
were from atrial fibrillation, extracranial carotid disease, or hemor-
rhage. Depending on this knowledge, we may be more apt to
perform more examinations with duplex scanning of the carotid
artery prior to these surgeries.
Dr Axelrod. I think that’s an important point. Unfortunately,
we were limited in that the NSQIP defined this as a composite end
point of all of those types of stroke and did not differentiate
between them. Further research should more carefully characterize
the cause and type of stroke, which might point us in the direction
of what type of preoperative and perioperative strategies to use.
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